Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapaquistat Acetate Extension Study in Hypercholesterolemia
NCT00868127Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
01
Overview
Phase 3, open-label trial of lapaquistat in hypercholesterolemia (2 arms), sponsored by Takeda. Primary endpoints: Adverse Events, Vital Signs and 8 more. Started Dec 2005; status: completed.
02
Drugs
lapaquistat
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00868127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00868127.